1419603-34-1

Basic information

• Product Name: 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide
• Synonyms: 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide
• CAS NO: 1419603-34-1
• Molecular Weight: 408.37
• Mol File: 1419603-34-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide(1419603-34-1)
• EPA Substance Registry System: 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide(1419603-34-1)

Safety Data

• Hazardous Substances Data: 1419603-34-1(Hazardous Substances Data)

Upstream product

• 1013335-78-8 5-bromopyridine-2-carboxylic acid chloride 
• 62-53-3 aniline 
• 1419603-32-9 5-bromo-N-phenylpyrimidine-2-carboxamide 
• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 
• 37131-87-6 5-bromo-2-pyrimidinecarboxylic acid 

Downstream Products

• 1419603-38-5 methyl 2-(2-(phenyl((2-(trimethylsilyl)ethoxy)methyl)carbamoyl)pyrimidin-5-yl)acrylate 
• 1419603-40-9 methyl 2-(2-(phenyl((2-(trimethylsilyl)ethoxy)-methyl)carbamoyl)pyrimidin-5-yl)propanoate 
• 1419603-42-1 2-(2-(phenylcarbamoyl)pyrimidin-5-yl)propanoic acid 
• 1419603-36-3 N-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-((2-(trimethylsilyl)ethoxy)-methyl)pyrimidine-2-carboxamide 
• 1421472-32-3 5-(1-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methylamino)-1-oxopropan-2-yl)-N-phenylpyrimidine-2-carboxamide 

Relevant articles and documents

Substituted Heterocyclic Aza Compounds

Heterocyclic aza compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also methods of using these compounds for the treatment and/or inhibition of pain and further diseases and/or disorders.

SUBSTITUTED HETEROCYCLIC AZA DERIVATIVES

The invention relates to heterocyclic aza derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.